RxSight (RXST) Accumulated Expenses (2020 - 2026)

RxSight (RXST) has reported Accumulated Expenses for 7 consecutive years, with $15.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accumulated Expenses fell 2.39% year-over-year to $15.6 million; the trailing twelve-month figure through Jun 2026 stood at $15.6 million (down 2.39% YoY), and the FY2025 full-year result was $16.5 million, down 18.79% from the prior year.
• Accumulated Expenses retreated to $15.6 million in Q2 2026 per RXST's latest filing, from $18.7 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $20.4 million in Q4 2024 and bottomed at $6.4 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $13.7 million across 5 years, with a median of $14.2 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses jumped 70.35% in 2022, then retreated 18.79% in 2025.
• Over 5 years, Accumulated Expenses stood at $12.7 million in 2022, then climbed by 20.26% to $15.2 million in 2023, then surged by 33.59% to $20.4 million in 2024, then decreased by 18.79% to $16.5 million in 2025, then dropped by 5.93% to $15.6 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $15.6 million, $18.7 million, and $16.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.